With a recent report showing 67% of medtech manufacturers are likely to reshore back to the US, additive manufacturing could come as a cost-saving goldmine.
There are multiple factors shaping medical device manufacturing. And this has been especially true over the last 3 years with a pandemic, war, economic uncertainty, and disrupted supply chains all creating cracks in the manufacturing ecosystem. While the industry has already seen its shakeups to address these challenges, 2023 seems to be the year in which many companies are implementing strategic changes to start patching the cracks in an effort to move toward more sustainable, and reliable, operation.
These strategies are creating trends in how many manufacturers currently operate. In Xometry’s 2023 Medical Device Manufacturing Report, two main changes noted were the uptick in additive manufacturing and reshoring.
